Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers

Background The mental health benefits of cannabidiol (CBD) are promising but can be inconsistent, in part due to challenges in defining an individual’s effective dosage. In schizophrenia, alterations in anandamide (AEA) concentrations, an endocannabinoid (eCB) agonist of the eCB system, reflect posi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Herta Flor, Oliver Grimm, Cathrin Rohleder, Dagmar Koethe, F Markus Leweke, Timothy A Couttas, Carola Boost, Franziska Pahlisch, Eliska B Sykorova, Juliane K Mueller, Beverly Jieu, Judith E Leweke, Inga Dammann, Anna E Hoffmann, Martin Loeffler, Frank Enning, Andreas Meyer-Lindenberg
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2024-08-01
Serie:	BMJ Mental Health
Accesso online:	https://ebmh.bmj.com/content/27/1/e301027.full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!